130 related articles for article (PubMed ID: 1279714)
1. Transplantation of stem cells enriched by immunoadsorption.
Berenson RJ; Bensinger WI; Kalamasz DF; Heimfeld S; Goffe RA; Berninger RW; Peterson DR; Thompson P; Strong DM
Prog Clin Biol Res; 1992; 377():449-57; discussion 458-9. PubMed ID: 1279714
[No Abstract] [Full Text] [Related]
2. Stem cell selection--clinical experience.
Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
[No Abstract] [Full Text] [Related]
4. Purging tumor cells from bone marrow or peripheral blood using avidin-biotin immunoadsorption.
Stray KM; Corpuz S; Kalamasz D; Colter M; Berenson R; Heimfeld S
Prog Clin Biol Res; 1994; 389():97-103. PubMed ID: 7535467
[No Abstract] [Full Text] [Related]
5. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
Civin CI
Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
[No Abstract] [Full Text] [Related]
6. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
Silvestri F; Baccarani M
Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
[TBL] [Abstract][Full Text] [Related]
7. CD34 or S313 positive cells selection by avidin-biotin immunoadsorption.
Tassi C; Fortuna A; Bontadini A; Lemoli RM; Gobbi M; Tazzari PL
Haematologica; 1991 Mar; 76 Suppl 1():41-3. PubMed ID: 1713873
[TBL] [Abstract][Full Text] [Related]
8. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow.
Hardwick A; Law P; Mansour V; Kulcinski D; Ishizawa L; Gee A
Prog Clin Biol Res; 1992; 377():583-9. PubMed ID: 1279728
[No Abstract] [Full Text] [Related]
9. CD34+ selected cells in clinical transplantation.
Collins RH
Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
[TBL] [Abstract][Full Text] [Related]
10. Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.
Lemoli RM; Tazzari PL; Fortuna A; Bolognesi A; Gulati SC; Stirpe F; Tura S
Bone Marrow Transplant; 1994 Apr; 13(4):465-71. PubMed ID: 7517259
[TBL] [Abstract][Full Text] [Related]
11. The AIS CELLector: a new technology for stem cell purification.
Okarma T; Lebkowski J; Schain L; Harvey M; Tricot G; Srour E; Meyers WG; Burnett A; Sniecinski I; O'Reilly RJ
Prog Clin Biol Res; 1992; 377():487-502; discussion 503-4. PubMed ID: 1279717
[No Abstract] [Full Text] [Related]
12. A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow.
Farley TJ; Preti RA; Ahmed T; Ciavarella D
Prog Clin Biol Res; 1994; 389():105-9. PubMed ID: 7535430
[No Abstract] [Full Text] [Related]
13. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
Noga SJ; Davis J; Schepers K; Eby L; Berenson RJ
Prog Clin Biol Res; 1994; 389():317-24. PubMed ID: 7535437
[No Abstract] [Full Text] [Related]
14. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytometry identification of CD34-positive cells].
Tichelli A; Kralj A; Huxol H; Schönenberger A; Rabaglio M; Borel J; Müller R; Bargetzi M; Gratwohl A; Signer E
Schweiz Med Wochenschr; 1995 Mar; 125(9):400-4. PubMed ID: 7534431
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of CD34+ hematopoietic precursors: clinical rationale.
Berenson RJ
Transplant Proc; 1992 Dec; 24(6):3032-4. PubMed ID: 1281584
[No Abstract] [Full Text] [Related]
17. CD34+ and CD33+ stem cells: predictors of hematologic recovery?
Ross RE; Jeter EK; Stuart RK; Self SE; Lavia MF
Prog Clin Biol Res; 1992; 377():505-12. PubMed ID: 1279718
[No Abstract] [Full Text] [Related]
18. Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation.
Körbling M; Drach J; Champlin RE; Engel H; Huynh L; Kleine HD; Berenson R; Deisseroth AB; Andreeff M
Bone Marrow Transplant; 1994 May; 13(5):649-54. PubMed ID: 7519938
[TBL] [Abstract][Full Text] [Related]
19. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
Arseniev L; Tischler HJ; Battmer K; Südmeier I; Casper J; Link H
Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.
Pico JL; Bourhis JH; Bennaceur AL; Beaujean F; Bayle C; Ibrahim A; Girinski T; Hayat M; Dighiero G; Tchernia G
Nouv Rev Fr Hematol (1978); 1995; 37(6):381-3. PubMed ID: 8907636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
